FORTIS vs INDRAMEDCO: Stock Comparison
FORTIS HEALTHCARE is the larger company by market capitalisation. FORTIS HEALTHCARE shows faster revenue growth, while INDRAPRASTHA MEDICAL CORP shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
FORTIS leads 5; INDRAMEDCO leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | FORTIS | INDRAMEDCO |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Hospital | Hospital |
Price
| Metric | FORTIS | INDRAMEDCO |
|---|---|---|
| Live Price | ₹887.8 | ₹355 |
| Day Change | -1.62% | -1.39% |
| Volume | 7.85 L | 1.85 L |
| 52-Week High | ₹1,104.3 | ₹640.85 |
| 52-Week Low | ₹766.8 | ₹342 |
| Distance from 52W High | -19.61% | -44.6% |
Valuation
| Metric | FORTIS | INDRAMEDCO |
|---|---|---|
| Market Cap | ₹66,987 Cr | ₹3,246 Cr |
| P/E Ratio | 63.93x | 17.26x |
| P/B Ratio | 6.77x | 4.38x |
| EPS | ₹3.53 | ₹6.09 |
| Book Value | ₹134.69 | ₹80.76 |
| Dividend Yield | 0.11% | 1.27% |
Growth
| Metric | FORTIS | INDRAMEDCO |
|---|---|---|
| Revenue Growth (TTM YoY) | 17.8% | 9.3% |
| EPS Growth (TTM YoY) | 44.3% | 1.8% |
| Qtr Sales Growth | 419.98% | 11.33% |
| Qtr Profit Growth | 470.95% | 33.93% |
Profitability & Leverage
| Metric | FORTIS | INDRAMEDCO |
|---|---|---|
| ROE | 10.47% | 24.8% |
| ROCE | 10.23% | 25.98% |
| Net Margin | 11.41% | 12.21% |
| Operating Margin | 18.23% | 17% |
| Debt to Equity | 0.28x | 0x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | FORTIS | INDRAMEDCO |
|---|---|---|
| Promoter Holding | 0% | 49.39% |
| FII Holding | 25.2%▼ 0.77 pp | 2.77%▲ 0.33 pp |
| DII Holding | 32.23%▲ 0.88 pp | 0.59%▼ 0.29 pp |
| Public Holding | 11.4%▼ 0.11 pp | 45.64%▼ 0.05 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FORTIS HEALTHCARE and INDRAPRASTHA MEDICAL CORP.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.